Jay S. Duker
CIK 1630864 · President and CEO · last filed 2026-03-24
Jay S. Duker is a President and CEO who has filed 40 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for EYPT, was dated Mar 24, 2026. Across all open-market trades the lifetime net is +$29.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.32M
4
40
$29.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EYPT | President and CEO | 178,417 | $13.03 | $2.32M | $29.2K | 30 | 2026-03-24 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | 40,000 | $12.58 | $503.0K | $0 | 5 | 2022-06-24 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 2 | 2017-12-19 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | — | — | — | $0 | 3 | 2017-05-23 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-24 | EYPT | Other (J) | — | $0 | EDGAR |
| 2026-03-16 | EYPT | Buy (P) | +1,500 | $19.7K | EDGAR |
| 2026-01-07 | EYPT | Mixed | +10,739 | -$169.5K | EDGAR |
| 2026-01-06 | EYPT | Mixed | +57,048 | -$662.7K | EDGAR |
| 2025-07-11 | EYPT | Mixed | +8,979 | -$85.0K | EDGAR |
| 2025-06-25 | EYPT | Other (J) | −56,665 | -$465.2K | EDGAR |
| 2025-03-20 | EYPT | Other (J) | −20,000 | -$123.1K | EDGAR |
| 2025-02-11 | EYPT | Mixed | +4,945 | -$13.3K | EDGAR |
| 2025-01-07 | EYPT | Mixed | +34,679 | -$135.7K | EDGAR |
| 2024-07-12 | EYPT | Mixed | +8,607 | -$70.0K | EDGAR |